Publications

Export 14 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Depressive Disorder, Major and Author is Turecki, Gustavo  [Clear All Filters]
2014
Berlim M, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G.  2014.  Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.. World J Biol Psychiatry. 15(7):570-8.
Chandley MJ, Szebeni A, Szebeni K, Crawford JD, Stockmeier CA, Turecki G, Kostrzewa RM, Ordway GA.  2014.  Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.. Int J Neuropsychopharmacol. 17(10):1569-78.
Lopez JPablo, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B, Maussion G, Yang JP, Yerko V, Vigneault E et al..  2014.  miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.. Nat Med. 20(7):764-8.
Mamdani F, Berlim M, Beaulieu M-M, Turecki G.  2014.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.. World J Biol Psychiatry. 15(2):135-44.
Amore M, Innamorati M, Di Vittorio C, Weinberg I, Turecki G, Sher L, Paris J, Girardi P, Pompili M.  2014.  Suicide attempts in major depressed patients with personality disorder.. Suicide Life Threat Behav. 44(2):155-66.
2015
Oh G, Wang S-C, Pal M, Chen ZFei, Khare T, Tochigi M, Ng C, Yang YA, Kwan A, Kaminsky ZA et al..  2015.  DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.. Biol Psychiatry. 77(3):246-55.
Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, Huang Y-Y, Giegling I, Rujescu D, Bureau A et al..  2015.  A genome-wide association study of suicidal behavior.. Am J Med Genet B Neuropsychiatr Genet. 168(7):557-63.
Maheu M, Lopez JP, Crapper L, Davoli MA, Turecki G, Mechawar N.  2015.  MicroRNA regulation of central glial cell line-derived neurotrophic factor (GDNF) signalling in depression.. Transl Psychiatry. 5:e511.
Chachamovich E, Kirmayer LJ, Haggarty JM, Cargo M, Mccormick R, Turecki G.  2015.  Suicide Among Inuit: Results From a Large, Epidemiologically Representative Follow-Back Study in Nunavut.. Can J Psychiatry. 60(6):268-75.
2016
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
2020
Belzeaux R, Gorgievski V, Fiori LM, Lopez JPablo, Grenier J, Lin R, Nagy C, Ibrahim EChérif, Gascon E, Courtet P et al..  2020.  GPR56/ADGRG1 is associated with response to antidepressant treatment.. Nat Commun. 11(1):1635.
Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R et al..  2020.  A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.. BMC Psychiatry. 20(1):268.
Nagy C, Maitra M, Tanti A, Suderman M, Théroux J-F, Davoli MAntonietta, Perlman K, Yerko V, Wang YChang, Tripathy SJ et al..  2020.  Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons.. Nat Neurosci. 23(6):771-781.
Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G et al..  2020.  Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.. J Clin Psychiatry. 81(4)